Colorado
The Board of Pharmacy is holding a pharmacy stakeholder meeting on August 4 at 3:00 pm Mountain time. The purpose of this Stakeholder Meeting is for the Board to receive feedback on proposed revisions on these proposed rules:
- Revisions to Rule 2.00.00. The purpose is to align the controlled substance transfer rule with new federal DEA requirements and clarifications.
- Revisions to Rules 3. The purpose is to implement HB 26-1336.
- Revisions to Rules 10.00.00 and 14.00.00. The purpose of the proposed revisions is to implement HB 26-1220.
- Revisions to Rule 11.00.00. The purpose is to align system automation and transfer of controlled substance prescriptions that align with new DEA requirements and practice standards.
- Revisions to Rules 3, 15 and 21. The purpose of these amendments is to refine compounding rules to better align with recent guidance from the FDA and to implement HB 26-1198.
- Repeal of Rule 28.00.00. The purpose of the repeal is to implement HB 26-1182.
- Revisions to Rule 19.00.00 – The purpose is to implement SB 26-032.
- Revisions to Rule 23. The purpose is to refine and define the length of time Prescription Drug Monitoring Program (PDMP) data is to be retained and/or archived to align better with other states and reduce risk where necessary.
- Correction to Appendix G. The purpose is to change the word provider to patient as it was originally intended and adopted by the Board.
Notice and Draft Rules
Ways to Participate
For more information, contact NACDS’ Mary Staples at 817-442-1155.
